Running marathons or endurance races is often seen as a hallmark of peak fitness. However, a groundbreaking new study led by Inova oncologist Tim Cannon, MD, Sheridan Director, Molecular Tumor Board and Co-Director of the Gastrointestinal Cancer Program at Inova Schar Cancer, reveals a surprising prevalence of precancerous colon growths among extreme runners. Recently featured in The New York Times, the study opens new discussions about screening opportunities.
Article links:
David Gordon, MD is a primary care is a primary care physician at Inova 360°…
Inova Schar Cancer is Northern Virginia’s only FACT-accredited health system https://vimeo.com/1158428376 There is an exciting…
More than three years after a stage IV metastatic breast cancer diagnosis, Amy’s scans are…
Inova ranks #32 in the country for Neonatology Fairfax, Virginia – Inova L.J. Murphy Children’s…
When Amal felt a sudden crack in her back while playing tennis at age 49,…
Colleen with her husband, Scott, in Great Smoky Mountains National Park. Since her diagnosis at…